Home › Parkinson's Disease › New York
Parkinson's Disease clinical trials in New York
31 studies for Parkinson's Disease are looking for participants at sites in New York.
Cities in New York
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
- Site-006, Albany
- Site-005, New York
RecruitingPhase 2/3
Ages 40 to 80 · All sexes · Updated Sep 28, 2026 · NCT06976268GBPDC: Gut-Brain in PD Consortium Master Protocol
- Columbia University, New York
RecruitingObservational studyHealthy volunteers welcome
Ages 21 to 80 · All sexes · Updated Sep 25, 2026 · NCT07567794Speech Learning and Speech Production in Parkinson's Disease
- State University of New York at Buffalo, Buffalo
Recruiting
Ages 45 and older · All sexes · Updated Sep 22, 2026 · NCT07403539Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease
- Weill Cornell Medical College, New York
RecruitingPhase 2
Ages 40 to 80 · All sexes · Updated Sep 21, 2026 · NCT07005180A Study of Buntanetap in Participants With PD
- Mount Sinai Hospital, New York
RecruitingPhase 2/3
Ages 40 to 85 · All sexes · Updated Sep 21, 2026 · NCT07284784Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
- Northwell Health Neuroscience Institute, Great Neck
- University at Buffalo, Williamsville
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT02071134A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
- Vima Site #055, Amherst
- Vima Site #024, New York
- Vima Site #052, Patchogue
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Sep 11, 2026 · NCT07804615A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
- Joan and Sanford I. Weill Department of Medicine (Site #224), New York
- Mount Sinai School of Medicine (Site #209), New York
RecruitingPhase 2
Ages 30 to 80 · All sexes · Updated Sep 10, 2026 · NCT07432958Parkinson's Foundation PD GENEration Genetic Registry
- Mount Sinai, New York
- Columbia University, New York
- University of Rochester Medical Center, Rochester
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT04994015A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
- Northwell Health, New York
- Stony Brook University, Stony Brook
- University of Buffalo Jacobs School of Medicine, Williamsville
RecruitingObservational study
Ages 45 to 75 · All sexes · Updated Sep 4, 2026 · NCT07330258Deep Brain Stimulation (DBS) Retrospective Outcomes Study
- Albany Medical Center, Albany
RecruitingObservational study
All ages · All sexes · Updated Sep 3, 2026 · NCT03664609A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- Dent Neurological Institute, Amherst
- Parkinson's Research Centers of America - Long Island, Commack
- Weill Cornell Medical College, New York
- and 1 more
RecruitingPhase 3
Ages 50 to 85 · All sexes · Updated Sep 3, 2026 · NCT07174310A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
- Northwell Health, Manhasset
- Icahn School of Medicine at Mount Sinai/Mount Sinai West, New York
- Columbia University, New York
- and 1 more
RecruitingPhase 2
Ages 40 to 80 · All sexes · Updated Aug 28, 2026 · NCT06680830Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage
- University of Rochester Center for Health and Technology (CHeT), Rochester
Recruiting
Ages 50 and older · All sexes · Updated Aug 27, 2026 · NCT06993142Young Onset Parkinson's Disease Subtypes and Pathogenic Mechanisms
- NYU Langone Health, New York
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Aug 12, 2026 · NCT07752355Autoimmune Features of Neurodegenerative Disorders
- Columbia University Medical Center, New York
RecruitingObservational studyHealthy volunteers welcome
Ages 55 to 90 · All sexes · Updated Aug 4, 2026 · NCT04239079A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
- UBMD Neurology, Buffalo
- Mount Sinai West - Neurology, New York
- New York Presbyterian/Weill Cornell Medical Center, New York
RecruitingPhase 3
Ages 45 to 75 · All sexes · Updated Aug 4, 2026 · NCT06944522Effects of Transcranial Focused Ultrasound Stimulation (tFUS) on Neurological and Cognitive Outcomes in Parkinson's Disease
- Radial Midtown Manhattan, New York
Recruiting
Ages 22 to 80 · All sexes · Updated Jul 31, 2026 · NCT07207122PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
- Beth Israel Medical Center, New York
- NYU Langone Health, New York
- University of Rochester, Rochester
RecruitingObservational studyHealthy volunteers welcome
Ages 30 and older · All sexes · Updated Jul 27, 2026 · NCT04477785A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)
- Columbia University, New York
RecruitingPhase 2
Ages 45 to 75 · All sexes · Updated Jun 29, 2026 · NCT06285643Effects of Osteopathic Manipulative Treatment Protocol on Sleep Quality in Parkinson's Disease Subjects
- New York Institute of Technology - College of Ostopathic Medicine - Academic Health Care Center - Osteopathic Medicine Center, Old Westbury
Recruiting
All ages · All sexes · Updated Jun 29, 2026 · NCT06671600Natural History Study of Synucleinopathies
- NYU Medical Center, New York
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 10, 2026 · NCT01799915Parkinson's Disease Biomarkers in Nerve Cells in the Gut
- Weill Cornell Medicine, New York
RecruitingObservational studyHealthy volunteers welcome
Ages 45 to 75 · All sexes · Updated May 22, 2026 · NCT05347407This Clinical Trial is Designed to Evaluate the Safety, Tolerability, Feasibility and Preliminary Efficacy of NouvNeu001 (Human Dopaminergic Progenitor Cells Injection) in Patients With Parkinson's Disease.
- Cornell University Weill Medical College, New York
RecruitingPhase 1/2
Ages 30 to 75 · All sexes · Updated May 11, 2026 · NCT07102342A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications
- Weill Cornell Medicine, New York
RecruitingObservational study
Ages 30 to 99 · All sexes · Updated Mar 20, 2026 · NCT05539196A Multicenter Study to Evaluate Safety, Tolerability, and Clinical Responses of DSP-1083 Into Subjects With Parkinson's Disease
- New York Presbyterian Hospital-Columbia University Medical Center, New York
RecruitingPhase 1/2
Ages 40 to 72 · All sexes · Updated Mar 2, 2026 · NCT06753331Abbott DBS Post-Market Study of Outcomes for Indications Over Time
- Albany Medical Center, Albany
RecruitingObservational study
All ages · All sexes · Updated Jan 8, 2026 · NCT04071847Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:
- Parkinson's Disease and Movement Disorders Center - Long Island, Commack
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 22, 2025 · NCT07219927A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
- Parkinson's Research Centers of America - Long Island, Commack
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Aug 24, 2025 · NCT06765668NYSCF Scientific Discovery Biobank
- New York Stem Cell Foundation Research Institute, New York
RecruitingObservational study
30 Days · All sexes · Updated Mar 3, 2025 · NCT06203106Noise-augmented Automatic Speech Recognition for Speech Treatment in Parkinson's Disease
- Teachers College, Columbia University, New York
RecruitingEarly phase 1
Ages 50 to 80 · All sexes · Updated Aug 15, 2024 · NCT06540989From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.